STVN - Stevanato Group S.p.A. Stock Analysis | Stock Taper
Logo

About Stevanato Group S.p.A.

https://www.stevanatogroup.com

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

Franco Stevanato

CEO

Franco Stevanato

Compensation Summary
(Year )

Total Compensation (Unknown At The Moment)
Industry Medical - Instruments & Supplies
Sector Healthcare
Went public July 16, 2021
Method of going public IPO
Full time employees 5,521

ETFs Holding This Stock

Ratings Snapshot

Rating : C+

Discounted Cash Flow 1
Return On Equity 3
Return On Assets 4
Debt To Equity 2
Price To Earnings 1
Price To Book 2
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Equal Weight 1
Neutral 1

Showing Top 2 of 2

Price Target

Target High $24
Target Low $24
Target Median $24
Target Consensus $24

Institutional Ownership